Molson Coors Beverage Company TAP has made premiumization a central pillar of its long-term growth strategy, aiming to enhance margins and consumer appeal. The company is actively shifting its portfolio toward higher-margin products such as Peroni, Madrí and Blue Moon, while also expanding its presence in the non-alcoholic and beyond-beer categories. Brands like Fever-Tree and ZOA are key investments in this space, reflecting Molson Coors’ ambition to serve a broader range of occasions and consumers, especially among Gen Z. These moves are designed to capitalize on evolving consumption trends and strengthen the company’s position beyond mainstream beer. Despite these efforts, Molson Coors is grappling with a challenging macroeconomic backdrop that continues to weigh heavily on volume performance. In first-quarter 2025, consolidated net sales revenues declined 10.4%, and U.S. financial volume dropped 15.7%, reflecting softer consumer demand and shipment headwinds. Although net sales revenue per hectoliter rose 4.8% in the Americas, driven largely by premium mix gains and pricing, this was not enough to fully offset the steep volume declines. These results suggest that while premiumization is helping to cushion the impact, it alone cannot fully counteract broad-based volume pressures. However, early signs from newer premium products are encouraging. Peroni, for example, has seen increased on-premise placements and retail expansion in the United States, aided by cost savings from onshore production. Similarly, Madrí is showing strong global growth, now a top 10 global brand for Molson Coors despite being just four years old. The company also launched Blue Moon Non-Alc and Blue Moon High ABV extensions, aiming to attract health-conscious and value-seeking consumers. These brands not only support margin growth but also help Molson Coors diversify away from declining contract brewing volumes. While premiumization is a vital part of Molson Coors’ growth story, it is not yet sufficient to fully offset the volume losses that are caused by macroeconomic headwinds and changing industry dynamics. Nonetheless, the company’s commitment to strengthening its premium portfolio, combined with disciplined cost management and innovation, positions it well for the medium to long term. If the broader beer category stabilizes and premium innovations continue to gain traction, Molson Coors could see greater balance between volume and value growth in the future. TAP’s Zacks Rank & Share Price Performance Shares of this Zacks Rank #5 (Strong Sell) company have lost 8.9% in the past six months, underperforming the Zacks Beverages - Soft Drinks industry’s growth of 9.7% and the broader Consumer Staples industry’s return of 6.8%. Story Continues TAP Stock's Six-Month PerformanceZacks Investment Research Image Source: Zacks Investment Research Is TAP Stock a Value Play? Molson Coors shares are currently trading at a forward 12-month price-to-earnings (P/E) multiple of 8.27X, which positions it at a discount compared with the industry’s average of 15.45X. The stock is undervalued compared with its industry peers, offering compelling value to investors looking for exposure to the consumer staple sector. TAP P/E Ratio (Forward 12 Months)Zacks Investment Research Image Source: Zacks Investment Research Key Picks Carlsberg CABGY, a brewing company with a beer portfolio of more than 500 brands, currently carries a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here. The Zacks Consensus Estimate for Carlsberg’s current financial-year sales and EPS indicates growth of 31.8% and 11.3%, respectively, from the prior-year reported levels. Zevia ZVIA is a beverage company that produces and sells various carbonated beverages in the United States and Canada. It currently carries a Zacks Rank #2. The consensus estimate for Zevia’s current year EPS implies growth of 48.4% from the year-ago reported number. ZVIA has a trailing four-quarter average earnings surprise of 33.6%. BRF S.A. BRFS raises, produces and slaughters poultry and pork for the processing, production and sale of fresh meat, processed products, pasta, margarine, pet food and other products. It currently carries a Zacks Rank #2. The Zacks Consensus Estimate for BRF S.A.'s current fiscal-year earnings implies growth of 8.3% from the prior-year levels. BRFS delivered a trailing four-quarter earnings surprise of 5.4%, on average. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Molson Coors Beverage Company (TAP):Free Stock Analysis Report BRF S.A. (BRFS):Free Stock Analysis Report Carlsberg AS (CABGY):Free Stock Analysis Report Zevia PBC (ZVIA):Free Stock Analysis Report This article originally published on Zacks Investment Research (zacks.com). Zacks Investment Research View Comments
Is Molson Coors' Focus on Premiumization Enough to Offset Soft Volume?
You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research. Learn more
Start Your Free Trial Now!Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research ReportsThis information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.
Please wait processing your request...